Abstract: Described herein are transdermal delivery devices composed of at least one re-sealable injection port and at least one local anesthetic reservoir. The device effectively delivers anesthetic to the skin of the subject prior to puncturing the skin by syringes, needle sticks, or other instruments intended to be inserted into the skin. In addition, this device can be used to deliver various therapeutic agents for either locally or systemically.

Abstract: Described herein are transdermal delivery devices composed of at least one resealable injection port and at least one local anesthetic reservoir. The device effectively delivers anesthetic to the skin of the subject prior to puncturing the skin by syringes, needle sticks, or other instruments intended to be inserted into the skin. In addition, this device can be used to deliver various therapeutic agents for either locally or systemically.

Abstract: This invention is for a method of treatment of rabies once the patient develops signs and symptoms of rabies with the intent to save the patients from death and disability using insulin combined with various anti rabies viral therapeutic, pharmaceutical, biochemical, and biological agents or compounds with added supportive therapies administered through OM, SAS, IVB, IV, and IA routes. An embodiment provides devices for intranasal delivery of therapeutic agents to olfactory mucosal area. Another embodiment uses the technology to deliver the therapeutic, pharmaceutical, biochemical, and biological agents or compounds to the subarachnoid space and ventricular system by using continuous catheters and Ommaya reservoir at the same time. The present method incorporates breaking the blood brain barrier to allow the entry of the anti rabies therapeutic agents into the neuropile. Additionally, an embodiment incorporates cooling of the brain and inducing hibernation to preserve the brain from damage due to rabies.

Abstract: The invention relates to the use of Rifampin and its related compound as a method of producing long-lasting, effective skin tanning for human and animal. The invention relates to methods of accelerating and facilitating the tanning of the skin using Rifampin along with use of the other tanning facilitators and accelerants with or without UVR.

Abstract: The invention relates to a method of instilling insulin ophthalmic drops in the conjunctival sac for treating retinitis pigmentosa due to any etiological factors both genetic and non genetic. The retinitis pigmentosa is treated with Insulin and/or IGF-I with or without known anti-retinitis pigmentosa therapeutic, pharmaceutical, biochemical, and biological agents or compounds. The invention furthermore uses this method as prophylactic on patients where the patients are predisposed to develop retinitis pigmentosa. The invention additionally treats other oculopathies associated with and/or contributing to retinitis pigmentosa.

Abstract: A light bulb includes two or more filaments. When one filament burns out another filament can be connected so that the light bulb is still operational and does not have to be discarded.

Abstract: A method of enhancing scalp hair growth utilizes insulin and/or IGF-1 alone or in combination with other known hair growth promoting therapeutic, pharmaceutical and biological agents to increase the therapeutic effects of hair regrowth strategies to enhance hair growth on the scalp and as method of treatment for balding.

Abstract: Described herein are transdermal delivery devices composed of at least one re-sealable injection port and at least one local anesthetic reservoir. The device effectively delivers anesthetic to the skin of the subject prior to puncturing the skin by syringes, needle sticks, or other instruments intended to be inserted into the skin. In addition, this device can be used to deliver various therapeutic agents for either locally or systemically.

Abstract: A modular lighting apparatus includes a replaceable bulb assembly, an adapter, and a mechanical and electrical connector assembly that removably connects the bulb assembly to the adapter for use. The bulb assembly includes a light-emitting component mounted to a body. In example embodiments the light-emitting component includes spiral-tube CFLs, low-profile transverse CFL tubes, and omni-directional LED arrays. The adapter includes a standard screw base mounted to a body that houses an electronic ballast. In this way, the bulb assembly can be removed from the adapter and replaced, while reusing the electronic ballast in the adapter. And the screw-base adapter allows the reuse of the electronic ballast in standard screw-socket household light fixtures. In addition, the reusable adapter base also may be provided with an integral photocell for light-based control of the lighting apparatus without increasing the overall height of the composite lighting apparatus.

Abstract: A method and apparatus for heating the interior surfaces of a hollow organ or orifice of the human body for the treatment of viral infections, microbial infections, and cancers, the apparatus including an insertion body 11 having a semi-rigid support tube 12 and an inflatable balloon 17. Conduits 38 and 39 connect the interior of the inflatable balloon 17 with a heating and pumping unit 31 for heating liquid and circulating liquid within the inflatable balloon to heat the outer surface of the inflatable balloon. For treating infections and cancers, the insertion body is inserted into the organ or orifice and inflated and heated to a selected temperature, e.g., 44.degree. C., and maintained at the temperature for an extended length of time, e.g., for four hours.